@slashgear.com 2 years ago
Pfizer may release an at-home COVID-19 treatment before the holidays
@xconomy.com 3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@slashgear.com 3 years ago
Gilead CEO answers big COVID-19 question: How much will remdesivir cost
@xconomy.com 4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com 4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com 4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com 5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@extremetech.com 5 years ago
23andMe, GlaxoSmithKline Will Use Your DNA to Develop New Drugs
@techcrunch.com 7 years ago
BenevolentBio’s artificial intelligence could discover a better treatment for ALS